1. Home
  2. LSBK vs INO Comparison

LSBK vs INO Comparison

Compare LSBK & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LSBK

Lake Shore Bancorp Inc.

N/A

Current Price

$16.99

Market Cap

123.3M

Sector

Finance

ML Signal

N/A

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.18

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSBK
INO
Founded
1891
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.3M
100.4M
IPO Year
2025
1999

Fundamental Metrics

Financial Performance
Metric
LSBK
INO
Price
$16.99
$1.18
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
8.5K
1.5M
Earning Date
04-22-2026
05-08-2026
Dividend Yield
2.27%
N/A
EPS Growth
49.23
54.18
EPS
0.26
N/A
Revenue
N/A
$42,220,086.00
Revenue This Year
N/A
$20,156.19
Revenue Next Year
N/A
$421.95
P/E Ratio
$65.38
N/A
Revenue Growth
N/A
19.37
52 Week Low
$11.50
$1.03
52 Week High
$17.96
$2.86

Technical Indicators

Market Signals
Indicator
LSBK
INO
Relative Strength Index (RSI) 55.15 51.80
Support Level $16.64 $1.03
Resistance Level $17.76 $1.24
Average True Range (ATR) 0.45 0.06
MACD -0.04 0.01
Stochastic Oscillator 29.17 53.85

Price Performance

Historical Comparison
LSBK
INO

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holding company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit, and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: